Navigation Links
Attempt to Build Artificial Muscles from Carbon Nanofibres in the Offing

An Indian origin scientist at the Rensselaer Polytechnic Institute in Troy, New York, is attempting to build artificial muscles using carbon nanofibres . Artificial muscles change length in response to a stimulus, thereby creating a smoother, more human-like motion than jerky electric motors or pneumatic devices. As such, they could be used to power robots, prosthetic limbs and artificial tissue for implantation, say scientists. Today's most promising artificial muscles are based on electroactive polymers (EAPs) - plastics that change shape when activated electrically or with chemicals. But they lack mechanical robustness and as a result soon succumb to fatigue and fail. To test the nanotubes ability to resist fatigue, the team led by Victor Pushparaj took a two-millimetre-square block in which many millions of nanotubes were aligned vertically, and repeatedly compressed it between two steel plates once every 0.75 seconds for over 100 hours. The team found that even after 500,000 compressions, in which the tubes were repeatedly squashed to 75 per cent of their original length, the block kept pinging back almost to its original shape. "The nanotubes buckled in a zig-zag shape but regained their original shapes when the load was released. The nanotubes buckled but regained their original shapes, said Pushparaj. The findings appear in Nature Nanotechnology, reports New Scientist.


Page: 1

Related medicine news :

1. Attempting Hypnosis for relaxation
2. Anxiety Can Increase The Risk Of Attempting Suicide In Men
3. Archbishop Slams Attempt to Legalize Abortion In Jamaica
4. Surgeon Attempts to Create A Surgical Hernia Feat
5. Attempting Of Suicide In Children Of Men With Stressful Job Is High
6. Suicide Attempts Shoot Up Among Alcoholics with Personality Disorder
7. Quota Row: Student Attempts Immolation
8. Special Behavioral Therapies made Women more likely to Attempt Suicide
9. Antidepressants may be Linked with Suicide Attempts in Teens
10. Mercy Attempt Allowed for 12 KGMU Students
11. Maoris at Higher Risk of Suicide Attempts
Post Your Comments:

(Date:12/1/2015)... ... 2015 , ... CloudLIMS today announced that it is the ... the New Products and Services category for its innovative product offering, BioTracer. ... that helps labs organize data and track samples with storage inventories. BioTracer's SaaS ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... must mark the film for accurate interpretation by the radiologist. The marking utensils ... inventor from Sacramento, Calif., has found a way to alleviate this problem. , ...
(Date:12/1/2015)... ... 2015 , ... McLean, VA., December 1, 2015 - Octo ... sprint agile development contract to support the National Geospatial-Intelligence Agency's (NGA) IT Services ... engineering, infrastructure, as well as operations and sustainment support to the NGA’s Agile ...
(Date:12/1/2015)... GA (PRWEB) , ... December 01, 2015 , ... ... supports SACC-GA and SACC-USA through membership and leadership since 2008. Gary ... Chair for SACC-USA . Gary has spent a significant amount of time ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation recognizes Tympani as ... Cisco Unified Contact Center solutions targeted to the high-end enterprise contact center marketplace. ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 1, 2015 Russia has always ... 70% of new drugs registered in Europe in ... --> Russia has always been a country ... drugs registered in Europe in 2015 were tested ... Russia has always been a country of choice ...
(Date:12/1/2015)... Dec. 1, 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... chronic pain, announced today that the company will present at ... December 1-3 at the Luxe Sunset Boulevard Hotel in ... CEO of Relmada Therapeutics, will present on Thursday, December 3, ... . Please register at least 10 minutes prior ...
(Date:12/1/2015)...   MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), ... filed an Investigational New Drug Application (IND) with the ... lead fully human antibody product HuMab 5B1 as a ... initiate the Phase I clinical trial early in 2016. ... The planned Phase I trial will evaluate the safety, ...
Breaking Medicine Technology: